Adrenergic regulation of c-fos expression in cultured BC3H1 muscle cells.
Administration of adrenergic agonists induced c-fos mRNA in the salivary glands of the mouse and in the heart of the mouse, rat, and hamster (Barka et al., 1986, Mol. Cell Biol. 6, 2984-2989; 1987; Oncogene 1, 439-443). To further analyze transcriptional and post-transcriptional control of c-fos expression by adrenergic receptors and the putative role of fos in replication and differentiation pathways, we have examined c-fos expression in BC3H1 cells, a tumor-derived nonfusing muscle cell line. BC3H1 cells possess alpha 1- and beta 2-adrenergic receptors as well as receptors for histamine and acetylcholine. Furthermore, rapidly proliferating BC3H1 cells undergo differentiation toward muscle phenotype when exposed to low serum-containing culture media. Both alpha- and beta-adrenergic agonists and the tumor promoter 12-O-tetradecanoylphorbol-13-acetate caused a rapid, transient increase in the steady-state level of c-fos mRNA. This induction was essentially independent of whether the cells were in the proliferative, relatively quiescent, or differentiated state. Protein synthesis inhibitors cycloheximide and anisomycin also increased markedly the concentration of c-fos mRNA, and in the presence of anisomycin c-fos mRNA was superinduced by the alpha-adrenergic agonist norepinephrine. Run-on transcription assays indicated that the c-fos gene is expressed in both proliferating and differentiated cells, although the steady-state levels of c-fos mRNA were low, or even undetectable, in such cells. The adrenergic agonists and the tumor promoter stimulated the transcription of the c-fos gene in both proliferating and differentiated cells. This stimulation, however, was modest, two- to three-fold compared to controls, in contrast to the marked elevation of the level of c-fos mRNA they caused. Neither the proliferation nor the expression of muscle type creatine kinase activity was influenced by adrenergic agonists. It is suggested that activation of the c-fos gene is a consequence of adrenoreceptor stimulation in diverse cell types, and thus it is involved in pleiotropic cellular responses to adrenergic agonists. Catecholamines may be one of the physiologic regulators of the c-fos gene.
Barka
T
T
Department of Anatomy, Mount Sinai School of Medicine, City University of New York, New York 10029.
van der Noen
H
H
Gresik
E W
EW
D000818:Animals; D002460:Cell Line; D003402:Creatine Kinase / Q000378:metabolism; D003513:Cycloheximide / Q000494:pharmacology; D004261:DNA Replication; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006632:Histamine / Q000494:pharmacology*; D007545:Isoproterenol / Q000494:pharmacology*; D008715:Methionine / Q000378:metabolism; D051379:Mice; D009132:Muscles; D009638:Norepinephrine / Q000494:pharmacology*; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D016760:Proto-Oncogene Proteins c-fos; D011519:Proto-Oncogenes / Q000187:drug effects; D012333:RNA, Messenger / Q000187:drug effects / Q000235:genetics; D011943:Receptors, Adrenergic, beta / Q000187:drug effects / Q000502:physiology*; D013462:Sulfur Radioisotopes; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D013936:Thymidine / Q000378:metabolism; D014158:Transcription, Genetic / Q000187:drug effects; D014316:Tritium
D011518:Proto-Oncogene Proteins; D016760:Proto-Oncogene Proteins c-fos; D012333:RNA, Messenger; D011943:Receptors, Adrenergic, beta; D013462:Sulfur Radioisotopes; D014316:Tritium; D006632:Histamine; D003513:Cycloheximide; D008715:Methionine; D011505:Protein-Tyrosine Kinases; D003402:Creatine Kinase; D007545:Isoproterenol; D013755:Tetradecanoylphorbol Acetate; D013936:Thymidine; D009638:Norepinephrine; D004121:Dimethyl Sulfoxide